Title

2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD

Authors

Janani Rangaswami
Katherine Tuttle, Providence St. Joseph HealthFollow
Muthiah Vaduganathan

Document Type

Presentation

Streaming Media

Publication Date

10-28-2020

Publication Title

AHA, Know Diabetes by Heart

Abstract

Listen to leading experts discuss the new Scientific Statement from the American Heart Association, “Cardiorenal Protection With the Newer Antidiabetic Agents in Patients With Diabetes and Chronic Kidney Disease,” where two newer groups of medications prescribed primarily for Type 2 diabetes treatment (SGLT2 inhibitors and GLP-1 receptor agonists) could significantly reduce risks associated with chronic kidney disease (CKD) and heart disease.

Clinical Institute

Cardiovascular (Heart)

Clinical Institute

Kidney & Diabetes

Department

Cardiology

Department

Endocrinology

Recommended Citation

Rangaswami, Janani; Tuttle, Katherine; and Vaduganathan, Muthiah, "2020 Episode 8 – Cardiorenal Protection in Patients with Diabetes and CKD" (2020). Articles, Abstracts, and Reports. 3924.
https://digitalcommons.providence.org/publications/3924